Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. OSG
OSG logo

OSG Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
6.240
Open
5.910
VWAP
5.65
Vol
1.65M
Mkt Cap
272.33M
Low
5.330
Amount
9.32M
EV/EBITDA(TTM)
54.42
Total Shares
45.01M
EV
675.28M
EV/OCF(TTM)
--
P/S(TTM)
0.90
Octave Specialty Group, Inc. is a global specialty insurance company that builds, buys, and scales niche insurance distribution and underwriting businesses. It provides strategic direction, risk oversight, data and technology solutions, and capital support to MGA businesses operating across the U.S., U.K., and Bermuda. Its build-and-buy strategy is executed by its incubation division, Octave Ventures, and its acquisition division, Octave Partners. At Octave Ventures, it helps specialty underwriters to set up their own company, leveraging its resources. It offers funding, infrastructure, risk capital, and A+ rated paper as well as experienced guidance and support to underwriters looking to launch their own MGAs. Octave Partners identifies high-performing MGAs that would benefit from its partnership and add value to its expanding portfolio. To facilitate growth, it provides expertise, technology, distribution and capacity relationships, expansion and cross-company sales opportunities.
Show More

Events Timeline

(ET)
2026-05-06
17:00:00
Octave Reports Q1 Revenue of $104.17M
select
2026-02-23 (ET)
2026-02-23
16:10:00
Octave Specialty Group Reports Q4 Revenue of $66.9M
select

News

seekingalpha
9.5
05-07seekingalpha
PinnedOctave Specialty Group Reports Strong Q1 2026 Earnings Growth
  • Insurance Distribution Growth: Octave Specialty Group's insurance distribution segment reported a 92% revenue increase to $78.5 million in Q1 2026, driven by 42% organic growth and the acquisition of ArmadaCare, highlighting the company's robust market performance and expansion potential.
  • Significant EBITDA Increase: Adjusted EBITDA for this segment reached $25 million, nearly quadrupling year-over-year, with margins expanding from 17% to 32%, reflecting substantial improvements in cost control and profitability.
  • Optimistic Future Outlook: Management anticipates launching at least 1-2 new businesses in 2026, maintaining a positive outlook despite market risks and seasonal fluctuations, indicating stability in strategic direction.
  • Capital Expenditures and Acquisitions: The company completed an additional 10% acquisition of Octave Ventures and invested in four other MGAs, with a total cost of approximately $44 million, demonstrating proactive measures in market consolidation and expansion.
seekingalpha
9.5
05-06seekingalpha
Ambac Financial Group Q1 Results Exceed Expectations
  • Earnings Beat: Ambac Financial Group reported a Q1 non-GAAP EPS of $0.37, surpassing expectations by $0.36, indicating a significant improvement in profitability and enhanced competitive positioning in the market.
  • Revenue Surge: The company achieved revenues of $104.17 million in Q1, reflecting a 66.0% year-over-year increase and exceeding market expectations by $19.33 million, showcasing strong business expansion and demand.
  • Stock Price Rally: Ambac's shares rose by 36.7% in after-hours trading, indicating a positive investor reaction to the earnings report, which may further bolster market confidence in the company's future growth prospects.
  • Loan Support: Octave Specialty secured an additional $40 million term loan, demonstrating financial flexibility and confidence in future developments, potentially providing necessary funding for subsequent business expansion.
Newsfilter
9.5
05-06Newsfilter
Octave Specialty Group Reports Significant Growth in Q1 Results
  • Insurance Distribution Growth: Octave Specialty Group's Insurance Distribution segment achieved total revenue of $79 million in Q1, a 92% increase, with 42% of this growth attributed to organic revenue, demonstrating the company's strong market performance and successful integration of acquisitions.
  • Net Income Turnaround: The company reported a net income of $13 million for Q1, compared to a net loss of $3 million in the same period last year, reflecting a robust recovery in the Insurance Distribution business and enhancing investor confidence in future profitability.
  • Significant EBITDA Improvement: Adjusted EBITDA for Q1 reached $25 million, up 257% from $7 million in the prior year, indicating substantial progress in cost control and operational efficiency.
  • Everspan Business Challenges: Despite Everspan's gross premiums growing 19% to $104 million, a net loss of $8 million was reported due to legal expenses from a potential litigation matter, highlighting the risks and challenges faced in the company's diversified operations.
seekingalpha
9.5
05-05seekingalpha
Ambac Financial Group Q1 Earnings Announcement Scheduled
  • Earnings Release Date: Ambac Financial Group is set to announce its Q1 earnings on May 6th after market close, with a consensus EPS estimate of $0.01, reflecting a significant year-over-year increase of 107.7%, which could enhance investor confidence in the company's recovery.
  • Revenue Growth Expectations: The consensus revenue estimate stands at $84.84 million, representing a 35.2% year-over-year growth, indicating positive performance driven by market demand recovery and business expansion, likely to have a favorable impact on stock price.
  • Historical Performance Review: Over the past two years, Ambac has beaten EPS and revenue estimates 50% of the time, suggesting a consistent performance that may bolster market confidence in its future financial results.
  • Estimates Revision Dynamics: In the last three months, EPS estimates have seen two upward revisions with no downward adjustments, while revenue estimates have had one upward revision, reflecting analysts' optimistic outlook on the company's future performance, potentially attracting more investor interest.
seekingalpha
8.5
04-07seekingalpha
Octave Specialty Group Secures $40M Loan Amendment
  • Credit Agreement Amendment: Octave Specialty Group (OSG) and its subsidiaries amended their credit agreement to secure an additional $40 million term loan, aimed at fulfilling obligations related to put rights exercised by minority shareholders of Cirrata UK in March 2026, thereby enhancing the company's financial flexibility.
  • Total Loan Amount Increase: Following the amendment, OSG's total term loans rise to $139,375,000, indicating the company's proactive measures in financing to support future operational and investment plans.
  • Loan Terms Consistency: The new term loan shares the same maturity date and interest rate as OSG's existing loans, reflecting a robust strategy in managing financing costs, which helps maintain financial stability.
  • Asset Pledge Security: In relation to the amendment, OSG pledged its interests in the capital stock of Everspan Holdings LLC, further securing the loan and demonstrating the company's commitment to its future financial obligations.
Newsfilter
1.0
03-23Newsfilter
Octave Specialty Group Announces 2026 Annual Meeting Details
  • Meeting Schedule: Octave Specialty Group, Inc. has announced that its 2026 Annual Meeting of Stockholders will be held virtually on May 28, 2026, at 11 a.m. (ET), ensuring convenient participation for shareholders.
  • Shareholder Eligibility: The record date for determining stockholders entitled to notice and vote at the annual meeting is set for the close of business on April 2, 2026, ensuring compliance and transparency in the voting process.
  • Company Overview: Octave Specialty Group is a global specialty insurance firm focused on building, buying, and scaling niche insurance distribution and underwriting businesses, aiming to create long-term shareholder value through operational excellence and innovation.
  • Transfer Restrictions: The Amended and Restated Certificate of Incorporation imposes substantial restrictions on the transfer of common stock, rendering any transfer void if it results in any person or group holding 5% or more of the stock, thereby maintaining stability in the shareholder structure.
Wall Street analysts forecast OSG stock price to rise
2 Analyst Rating
Wall Street analysts forecast OSG stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
15.00
Averages
15.00
High
15.00
Current: 0.000
sliders
Low
15.00
Averages
15.00
High
15.00
No data

No data

Valuation Metrics

The current forward P/E ratio for Octave Specialty Group Inc (OSG.N) is 42.37, compared to its 5-year average forward P/E of 23.26. For a more detailed relative valuation and DCF analysis to assess Octave Specialty Group Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
23.26
Current PE
42.37
Overvalued PE
62.47
Undervalued PE
-15.96

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
23.43
Current EV/EBITDA
-6.76
Overvalued EV/EBITDA
61.72
Undervalued EV/EBITDA
-14.85

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.84
Current PS
0.72
Overvalued PS
1.11
Undervalued PS
0.57

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

highest option premium stocks
Intellectia · 46 candidates
Is Optionable: TrueOption Iv Rank: >= 80
Ticker
Name
Market Cap$
top bottom
OSG logo
OSG
Octave Specialty Group Inc
207.68M
CNNE logo
CNNE
Cannae Holdings Inc
563.31M
CBAN logo
CBAN
Colony Bankcorp Inc
429.04M
GENC logo
GENC
Gencor Industries Inc
220.31M
PLOW logo
PLOW
Douglas Dynamics Inc
970.25M
MBLY logo
MBLY
Mobileye Global Inc
6.27B
RSI below 30 and MACD turning Bullish
Intellectia · 8 candidates
Rsi 14: 0 - 30Moving Average Relationship: PriceCrossAboveMA5
Ticker
Name
Market Cap$
top bottom
CORT logo
CORT
Corcept Therapeutics Inc
3.82B
ELME logo
ELME
Elme Communities
280.35M
OSG logo
OSG
Octave Specialty Group Inc
276.45M
PSTV logo
PSTV
Plus Therapeutics Inc
52.05M
ATRA logo
ATRA
Atara Biotherapeutics Inc
33.17M
APLT logo
APLT
Applied Therapeutics Inc
14.63M

Whales Holding OSG

T
Tontine Management, LLC
Holding
OSG
+32.41%
3M Return
C
Caption Management, LLC
Holding
OSG
+14.62%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Octave Specialty Group Inc (OSG) stock price today?

The current price of OSG is 5.37 USD — it has decreased -11.24

What is Octave Specialty Group Inc (OSG)'s business?

Octave Specialty Group, Inc. is a global specialty insurance company that builds, buys, and scales niche insurance distribution and underwriting businesses. It provides strategic direction, risk oversight, data and technology solutions, and capital support to MGA businesses operating across the U.S., U.K., and Bermuda. Its build-and-buy strategy is executed by its incubation division, Octave Ventures, and its acquisition division, Octave Partners. At Octave Ventures, it helps specialty underwriters to set up their own company, leveraging its resources. It offers funding, infrastructure, risk capital, and A+ rated paper as well as experienced guidance and support to underwriters looking to launch their own MGAs. Octave Partners identifies high-performing MGAs that would benefit from its partnership and add value to its expanding portfolio. To facilitate growth, it provides expertise, technology, distribution and capacity relationships, expansion and cross-company sales opportunities.

What is the price predicton of OSG Stock?

Wall Street analysts forecast OSG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OSG is15.00 USD with a low forecast of 15.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Octave Specialty Group Inc (OSG)'s revenue for the last quarter?

Octave Specialty Group Inc revenue for the last quarter amounts to 104.17M USD, increased 65.99

What is Octave Specialty Group Inc (OSG)'s earnings per share (EPS) for the last quarter?

Octave Specialty Group Inc. EPS for the last quarter amounts to -0.13 USD, decreased -89.34

How many employees does Octave Specialty Group Inc (OSG). have?

Octave Specialty Group Inc (OSG) has 275 emplpoyees as of May 10 2026.

What is Octave Specialty Group Inc (OSG) market cap?

Today OSG has the market capitalization of 272.33M USD.